Telo Genomics announced that its blood test detected myeloma cells more often than earlier observations. No additional details were provided at the time of reporting.
Further verified information was not immediately available.


Telo Genomics said its blood test identified myeloma cells at a higher frequency than previously reported.

Telo Genomics announced that its blood test detected myeloma cells more often than earlier observations. No additional details were provided at the time of reporting.
Further verified information was not immediately available.

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Plus de Priya Anand →

